March 2014

Publications for March 2014

Pilot-testing an applied competency-based approach to Health Human Resources Planning using the context of an influenza pandemic.

Joanne M. Langley

Health Policy and Planning. , Accepted. October 2012.

The Vaccine Uptake Research Gap in Low-and Middle-Income Countries.

Noni E. MacDonald and Jennifer Smith

Evidence–Based Child Health , 2012; 7: 1013–1014.

Splenectomy: reducing the risk of infection.

Joanne M. Langley and Shelly McNeil

CMAJ , Letter to the Editor. 2012 November 20: 184(17):1926.

RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.

Sarah McAlpine, Yan Yan Huang and Robert Anderson

PLoS One , 2012 (7), e34055.

Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.

Scott A. Halperin, Song F. Lee and Jun Wang

Vaccine , 2012;30:350–360. doi: 10.1016/j.vaccine.2011.10.086.

Risk factors and outcomes with pandemic H1N1 influenza compared to seasonal influenza in hospitalized children in China.

Noni E. MacDonald and Qingli Zhang

Can J Infect Dis Med Microbiol , 2012; 23:199-203.

Endothelial cell surface expression of protein disulfide isomerase activates b1 and b3 integrins and facilitates dengue virus infection.

Robert Anderson

J Cell. Biochem , 113, 1681-1691.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.

Scott A. Halperin

Pediatr Infect Dis J. , 2012; 31:72–77. doi:10.1097/INF.0b013e318233049d.

Comparison of children hospitalized with seasonal versus pandemic influenza A, 2004–2009.

Scott A. Halperin

Pediatr Infect Dis J. , 2012; 130:397–406. doi:10.1542/peds.2011-3216

Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: A randomized, open-label study.

Scott A. Halperin

Pediatr Infect Dis J. , . 2013; 32:54–61. doi:10.1097/INF.0b013e3182717edf.